Vigil Neuroscience Inc

NASDAQ:VIGL  
12.27
+0.17 (+1.40%)
6:12:29 PM EDT: $12.55 +0.28 (+2.28%)
Earnings Announcements

Vigil Neuroscience Reports Third Quarter 2022 Results

Published: 11/10/2022 12:40 GMT
Vigil Neuroscience Inc (VIGL) - Vigil Neuroscience Reports Third Quarter 2022 Financial Results and Provides Business Update.
Announced Interim Topline Data From Phase 1 Trial of Vgl101 in Healthy Volunteers.
Cash and Cash Equivalents Were $203.9 Million As of September 30, 2022.
Qtrly Loss per Share $0.53.
Q3 Earnings per Share View $-0.60 -- Refinitiv Ibes Data (analyst estimates).completed $75 Million Pipe From New and Existing Investors, Extending Cash Runway Into Q1 of 2025.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.58

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.